Novartis International AG (CH) - Novartis sells US rights to the overactive bladder treatment Enablex - Drugs.com MedNews
Links shared publicly online about this topic.
- 850total visits
Novartis International AG (CH) - Novartis sells US rights to the overactive bladder treatment Enablex - Drugs.com MedNews
Novartis to receive USD 400 million cash payment from Irish based specialty pharmaceutical company Warner Chilcott Warner Chilcott to assume Enablex marketing,
View full resource at drugs.com
Tags: Urinary System, Overactive Bladder, Overactive Bladder Medication, Drug, Enablex, Novartis, Bladder Dysfunction
Most Recently Shared on September 24, 2010 at 2:09 pm By:
Novartis International AG (CH) - Novartis sells US rights to the overactive bladder treatment Enablex: * Nova... http://bit.ly/9KpuoH #drug
Advertisement
